ConductScience.org, home

Paper9962

Renin and beta-adenoceptor blockade-the mechanism of the hypotensive effect?

Hamer J. Br J Clin Pharmacol, 1976. Cited by 3 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Renin and beta-adenoceptor blockade-the mechanism of the hypotensive effect? Papers, record 9962. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9962

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Renin and beta-adenoceptor blockade-the mechanism of the hypotensive effect?
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1976
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.2
iCite
Revised in PubMed
2019-05-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hamer JJ

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
Blood PressureMajor topic
HypertensionMajor topic
ReninMajor topic
Dose-Response Relationship, Drug
Humans
Time Factors

Source PubMed

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,056,279Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.Clin Sci Mol Med Suppl1975https://conductscience.org/library/papers/1056279PubMed
21,178,006Editorial: Non-beta-blocking actions of propranolol.N Engl J Med1975https://conductscience.org/library/papers/1178006PubMed
314,172,036USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.Br Med J1964https://conductscience.org/library/papers/14172036PubMed
44,111,575Raised plasma-catecholamines in some patients with primary hypertension.Lancet1972https://conductscience.org/library/papers/4111575PubMed
54,124,993Lack of association between plasma-renin and history of heart-attack or stroke in patients with essential hypertension.Lancet1973https://conductscience.org/library/papers/4124993PubMed
64,136,053Renal abnormality of essential hypertension.Lancet1974https://conductscience.org/library/papers/4136053PubMed
74,149,613Beta-blockers and plasma renin activity in hypertension.Br Med J1974https://conductscience.org/library/papers/4149613PubMed
84,257,928Essential hypertension: renin and aldosterone, heart attack and stroke.N Engl J Med1972https://conductscience.org/library/papers/4257928PubMed
94,294,498Renin-angiotensin-aldosterone system during chronic thiazide therapy of benign hypertension.Circulation1968https://conductscience.org/library/papers/4294498PubMed
104,426,165Specificity of blockade of renal renin release by propranolol in the cat.Clin Sci Mol Med1974https://conductscience.org/library/papers/4426165PubMed
114,700,008Plasma renin levels and vascular complications in hypertension.Br Med J1973https://conductscience.org/library/papers/4700008PubMed
1247,018Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?Lancet1975https://conductscience.org/library/papers/47018PubMed
134,729,721Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.Am J Cardiol1973https://conductscience.org/library/papers/4729721PubMed
145,077,516Effects of chronic beta-adrenergic blockade on systemic and renal haemodynamic responses to hyperosmotic saline in hypertensive patients.Clin Sci1972https://conductscience.org/library/papers/5077516PubMed
155,084,985Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.N Engl J Med1972https://conductscience.org/library/papers/5084985PubMed
1653,401Letter: Saralasin bolus test.Lancet1975https://conductscience.org/library/papers/53401PubMed
175,640,885The paradox of beta-adrenergic blockade in hypertension.Circulation1968https://conductscience.org/library/papers/5640885PubMed
18764,929Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.Br Med J1976https://conductscience.org/library/papers/764929PubMed
19791,319Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.Br J Clin Pharmacol1975https://conductscience.org/library/papers/791319PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
37,874Diuretics, beta-blockers or both as treatment for essential hypertension.Br J Clin Pharmacol1979https://conductscience.org/library/papers/37874

Source PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5,972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9962

GET https://conductscience.org/api/papers/v1/9962/authors